Register
Digital English
Target groups: physiotherapists / Cesar/Mensendieck exercise therapists / edema physiotherapists
Line: First line / second line
Start date: Thursday 19 June 2025
End date: Thursday 19 June 2025
Participants: Minimal 20, maximal 60
Average score:
(8.5/10)
137 beoordelingen
Study load: 6 hours
Contact hours: 6
Contact days: 1
Language: English
Ratio practice and theory: Mostly theoretical
Level: expert
Code number: 2504251
E learning: No
Masterclass: Yes
Exam: No
Certificate: Yes

Program and other relevant information for participants

As a participant you get access to the private website www.npicursus.nl.
Here you can find all information; e.g.: schedule, preparations, updates.

Videotrailer

Date

Thursdaymiddag en -avond 19 June 2025

Costs

Euro 260,-

Location

  • Online

Accreditation

This course is accredited for registers: Basisregister Algemeen fysiotherapeut (Kwaliteitshuis - KRF en SKF) / Aantekeningenregister Oedeemfysiotherapeut (NVFL) / Oefentherapeut (coulance regeling) / Deelregister Oncologiefysiotherapeut (NVFL) with 6 points.

Prerequisites

Oncology physiotherapists and (lymphedema) physiotherapists who have completed the necessary training in the field of oncology & physiotherapy and have extensive experience in guiding oncology patients.

Learning outcome

The goal of this masterclass is to provide the most recent insights about the role of physical training in cancer rehabilitation and its influence on the survival chances of cancer patients. The participants will also gain more knowledge about basic exercise physiological mechanisms of training in (ex) cancer patients and will learn how to use this knowledge in tailor-made provision of physiotherapy to this group of patients.

Description

This masterclass will be conducted by Lee Jones, PhD, an international expert in the field of 'exercise oncology'. Lee Jones is professor and researcher at the prestigious Memorial Sloan Kettering Cancer Center (MSKCC) in New York, USA.

Dr. Jones will review the latest evidence and implications for exercise prescription in four distinct areas of exercise oncology:

  1. Exercise therapy during cancer treatment to attenuate physiological toxicity 
    In this area, Dr. Jones will review the latest evidence supporting the effects and tolerability of structured exercise therapy on cardiorespiratory fitness in patients receiving active cancer treatment (chemotherapy, androgen deprivation therapy).

  2. Exercise therapy after the completion of definitive adjuvant therapy to off-set late-occurring physiological toxicities 
    In this area, Dr. Jones will review the latest evidence supporting the effects and tolerability of structured exercise therapy to attenuate / recover from the late physiological consequences of cancer treatment.

  3. Exercise and cancer pathogenesis 
    In this lecture, Dr. Jones will review a precision, translational medicine approach to the development of exercise as a candidate anticancer strategy.

  4. Exercise to enhance cancer treatment efficacy
    In the final lecture, Dr. Jones will review the latest evidence supporting the combinatorial effects of exercise to improve the efficacy of cancer treatments on cancer control outcomes.

Teacher

  • Lee Jones PhD, professor and researcher at the Memorial Sloan Kettering Cancer Center, New York, USA

Course leaders

  • Lee Jones PhD, professor and researcher at the Memorial Sloan Kettering Cancer Center, New York, USA
  • Michael Schermer, Dutch Institute of Allied Healthcare

Didactics

Lecture and discussion

NPi contact persons

General and administrative questions

jolanda-kok-aleven Jolanda Kok-Aleven
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
telephone: 06 82 84 50 81
(bereikbaar ma. ochtend, dinsdag, woensdag, don. ochtend en vrijdag)

Contextual questions

michael-schermer Michael Schermer
email: This email address is being protected from spambots. You need JavaScript enabled to view it.
telephone: 06 15 87 16 73